Lurasidone Hydrochloride Generics Industry Research Report 2025
Description
Summary
According to APO Research, the global Lurasidone Hydrochloride Generics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lurasidone Hydrochloride Generics include Chia Tai Tianqing Pharmaceutical, Zhejiang Huahai Pharmaceutical, YaoPharma, Yangtze River Pharmaceutical, SJZ No.4 Pharmaceutical, Shandong Jewim Pharmaceutical, Qilu Pharmaceutical, Hansoh Pharma and Hisun Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lurasidone Hydrochloride Generics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lurasidone Hydrochloride Generics.
The report will help the Lurasidone Hydrochloride Generics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Lurasidone Hydrochloride Generics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lurasidone Hydrochloride Generics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Lurasidone Hydrochloride Generics Segment by Company
Chia Tai Tianqing Pharmaceutical
Zhejiang Huahai Pharmaceutical
YaoPharma
Yangtze River Pharmaceutical
SJZ No.4 Pharmaceutical
Shandong Jewim Pharmaceutical
Qilu Pharmaceutical
Hansoh Pharma
Hisun Pharmaceuticals
Cisen Pharmaceutical
Changzhou Pharmaceutical Factory
Zydus
Sun Pharmaceuticals
MSN
Lupin
Dr. Reddy's Laboratories
Amneal
Alkem
Alembic pharmaceuticals
Accord Healthcare
Lurasidone Hydrochloride Generics Segment by Type
20mg per Tablet
40mg per Tablet
60mg per Tablet
80mg per Tablet
120mg per Tablet
Lurasidone Hydrochloride Generics Segment by Application
Schizophrenia
Bipolar Depression
Lurasidone Hydrochloride Generics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone Hydrochloride Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lurasidone Hydrochloride Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone Hydrochloride Generics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lurasidone Hydrochloride Generics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lurasidone Hydrochloride Generics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lurasidone Hydrochloride Generics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
According to APO Research, the global Lurasidone Hydrochloride Generics market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.
North American market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Europe market for Lurasidone Hydrochloride Generics is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lurasidone Hydrochloride Generics include Chia Tai Tianqing Pharmaceutical, Zhejiang Huahai Pharmaceutical, YaoPharma, Yangtze River Pharmaceutical, SJZ No.4 Pharmaceutical, Shandong Jewim Pharmaceutical, Qilu Pharmaceutical, Hansoh Pharma and Hisun Pharmaceuticals, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Lurasidone Hydrochloride Generics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lurasidone Hydrochloride Generics.
The report will help the Lurasidone Hydrochloride Generics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
The Lurasidone Hydrochloride Generics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lurasidone Hydrochloride Generics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
Lurasidone Hydrochloride Generics Segment by Company
Chia Tai Tianqing Pharmaceutical
Zhejiang Huahai Pharmaceutical
YaoPharma
Yangtze River Pharmaceutical
SJZ No.4 Pharmaceutical
Shandong Jewim Pharmaceutical
Qilu Pharmaceutical
Hansoh Pharma
Hisun Pharmaceuticals
Cisen Pharmaceutical
Changzhou Pharmaceutical Factory
Zydus
Sun Pharmaceuticals
MSN
Lupin
Dr. Reddy's Laboratories
Amneal
Alkem
Alembic pharmaceuticals
Accord Healthcare
Lurasidone Hydrochloride Generics Segment by Type
20mg per Tablet
40mg per Tablet
60mg per Tablet
80mg per Tablet
120mg per Tablet
Lurasidone Hydrochloride Generics Segment by Application
Schizophrenia
Bipolar Depression
Lurasidone Hydrochloride Generics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lurasidone Hydrochloride Generics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Lurasidone Hydrochloride Generics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lurasidone Hydrochloride Generics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Lurasidone Hydrochloride Generics manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Lurasidone Hydrochloride Generics by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Lurasidone Hydrochloride Generics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.
Table of Contents
144 Pages
- 1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
- 2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Lurasidone Hydrochloride Generics Market Size (2020-2031)
- 2.2.2 Global Lurasidone Hydrochloride Generics Sales (2020-2031)
- 2.2.3 Global Lurasidone Hydrochloride Generics Market Average Price (2020-2031)
- 2.3 Lurasidone Hydrochloride Generics by Type
- 2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
- 2.3.2 20mg per Tablet
- 2.3.3 40mg per Tablet
- 2.3.4 60mg per Tablet
- 2.3.5 80mg per Tablet
- 2.3.6 120mg per Tablet
- 2.4 Lurasidone Hydrochloride Generics by Application
- 2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
- 2.4.2 Schizophrenia
- 2.4.3 Bipolar Depression
- 3 Market Competitive Landscape by Manufacturers
- 3.1 Global Lurasidone Hydrochloride Generics Market Competitive Situation by Manufacturers (2020 Versus 2024)
- 3.2 Global Lurasidone Hydrochloride Generics Sales (K Units) of Manufacturers (2020-2025)
- 3.3 Global Lurasidone Hydrochloride Generics Revenue of Manufacturers (2020-2025)
- 3.4 Global Lurasidone Hydrochloride Generics Average Price by Manufacturers (2020-2025)
- 3.5 Global Lurasidone Hydrochloride Generics Industry Ranking, 2023 VS 2024 VS 2025
- 3.6 Global Manufacturers of Lurasidone Hydrochloride Generics, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Lurasidone Hydrochloride Generics, Product Type & Application
- 3.8 Global Manufacturers of Lurasidone Hydrochloride Generics, Established Date
- 3.9 Global Lurasidone Hydrochloride Generics Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
- 4 Manufacturers Profiled
- 4.1 Chia Tai Tianqing Pharmaceutical
- 4.1.1 Chia Tai Tianqing Pharmaceutical Company Information
- 4.1.2 Chia Tai Tianqing Pharmaceutical Business Overview
- 4.1.3 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.1.4 Chia Tai Tianqing Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 4.1.5 Chia Tai Tianqing Pharmaceutical Recent Developments
- 4.2 Zhejiang Huahai Pharmaceutical
- 4.2.1 Zhejiang Huahai Pharmaceutical Company Information
- 4.2.2 Zhejiang Huahai Pharmaceutical Business Overview
- 4.2.3 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.2.4 Zhejiang Huahai Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 4.2.5 Zhejiang Huahai Pharmaceutical Recent Developments
- 4.3 YaoPharma
- 4.3.1 YaoPharma Company Information
- 4.3.2 YaoPharma Business Overview
- 4.3.3 YaoPharma Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.3.4 YaoPharma Lurasidone Hydrochloride Generics Product Portfolio
- 4.3.5 YaoPharma Recent Developments
- 4.4 Yangtze River Pharmaceutical
- 4.4.1 Yangtze River Pharmaceutical Company Information
- 4.4.2 Yangtze River Pharmaceutical Business Overview
- 4.4.3 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.4.4 Yangtze River Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 4.4.5 Yangtze River Pharmaceutical Recent Developments
- 4.5 SJZ No.4 Pharmaceutical
- 4.5.1 SJZ No.4 Pharmaceutical Company Information
- 4.5.2 SJZ No.4 Pharmaceutical Business Overview
- 4.5.3 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.5.4 SJZ No.4 Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 4.5.5 SJZ No.4 Pharmaceutical Recent Developments
- 4.6 Shandong Jewim Pharmaceutical
- 4.6.1 Shandong Jewim Pharmaceutical Company Information
- 4.6.2 Shandong Jewim Pharmaceutical Business Overview
- 4.6.3 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.6.4 Shandong Jewim Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 4.6.5 Shandong Jewim Pharmaceutical Recent Developments
- 4.7 Qilu Pharmaceutical
- 4.7.1 Qilu Pharmaceutical Company Information
- 4.7.2 Qilu Pharmaceutical Business Overview
- 4.7.3 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.7.4 Qilu Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 4.7.5 Qilu Pharmaceutical Recent Developments
- 4.8 Hansoh Pharma
- 4.8.1 Hansoh Pharma Company Information
- 4.8.2 Hansoh Pharma Business Overview
- 4.8.3 Hansoh Pharma Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.8.4 Hansoh Pharma Lurasidone Hydrochloride Generics Product Portfolio
- 4.8.5 Hansoh Pharma Recent Developments
- 4.9 Hisun Pharmaceuticals
- 4.9.1 Hisun Pharmaceuticals Company Information
- 4.9.2 Hisun Pharmaceuticals Business Overview
- 4.9.3 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.9.4 Hisun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
- 4.9.5 Hisun Pharmaceuticals Recent Developments
- 4.10 Cisen Pharmaceutical
- 4.10.1 Cisen Pharmaceutical Company Information
- 4.10.2 Cisen Pharmaceutical Business Overview
- 4.10.3 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.10.4 Cisen Pharmaceutical Lurasidone Hydrochloride Generics Product Portfolio
- 4.10.5 Cisen Pharmaceutical Recent Developments
- 4.11 Changzhou Pharmaceutical Factory
- 4.11.1 Changzhou Pharmaceutical Factory Company Information
- 4.11.2 Changzhou Pharmaceutical Factory Business Overview
- 4.11.3 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.11.4 Changzhou Pharmaceutical Factory Lurasidone Hydrochloride Generics Product Portfolio
- 4.11.5 Changzhou Pharmaceutical Factory Recent Developments
- 4.12 Zydus
- 4.12.1 Zydus Company Information
- 4.12.2 Zydus Business Overview
- 4.12.3 Zydus Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.12.4 Zydus Lurasidone Hydrochloride Generics Product Portfolio
- 4.12.5 Zydus Recent Developments
- 4.13 Sun Pharmaceuticals
- 4.13.1 Sun Pharmaceuticals Company Information
- 4.13.2 Sun Pharmaceuticals Business Overview
- 4.13.3 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.13.4 Sun Pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
- 4.13.5 Sun Pharmaceuticals Recent Developments
- 4.14 MSN
- 4.14.1 MSN Company Information
- 4.14.2 MSN Business Overview
- 4.14.3 MSN Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.14.4 MSN Lurasidone Hydrochloride Generics Product Portfolio
- 4.14.5 MSN Recent Developments
- 4.15 Lupin
- 4.15.1 Lupin Company Information
- 4.15.2 Lupin Business Overview
- 4.15.3 Lupin Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.15.4 Lupin Lurasidone Hydrochloride Generics Product Portfolio
- 4.15.5 Lupin Recent Developments
- 4.16 Dr. Reddy's Laboratories
- 4.16.1 Dr. Reddy's Laboratories Company Information
- 4.16.2 Dr. Reddy's Laboratories Business Overview
- 4.16.3 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.16.4 Dr. Reddy's Laboratories Lurasidone Hydrochloride Generics Product Portfolio
- 4.16.5 Dr. Reddy's Laboratories Recent Developments
- 4.17 Amneal
- 4.17.1 Amneal Company Information
- 4.17.2 Amneal Business Overview
- 4.17.3 Amneal Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.17.4 Amneal Lurasidone Hydrochloride Generics Product Portfolio
- 4.17.5 Amneal Recent Developments
- 4.18 Alkem
- 4.18.1 Alkem Company Information
- 4.18.2 Alkem Business Overview
- 4.18.3 Alkem Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.18.4 Alkem Lurasidone Hydrochloride Generics Product Portfolio
- 4.18.5 Alkem Recent Developments
- 4.19 Alembic pharmaceuticals
- 4.19.1 Alembic pharmaceuticals Company Information
- 4.19.2 Alembic pharmaceuticals Business Overview
- 4.19.3 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.19.4 Alembic pharmaceuticals Lurasidone Hydrochloride Generics Product Portfolio
- 4.19.5 Alembic pharmaceuticals Recent Developments
- 4.20 Accord Healthcare
- 4.20.1 Accord Healthcare Company Information
- 4.20.2 Accord Healthcare Business Overview
- 4.20.3 Accord Healthcare Lurasidone Hydrochloride Generics Sales, Revenue and Gross Margin (2020-2025)
- 4.20.4 Accord Healthcare Lurasidone Hydrochloride Generics Product Portfolio
- 4.20.5 Accord Healthcare Recent Developments
- 5 Global Lurasidone Hydrochloride Generics Market Scenario by Region
- 5.1 Global Lurasidone Hydrochloride Generics Market Size by Region: 2020 VS 2024 VS 2031
- 5.2 Global Lurasidone Hydrochloride Generics Sales by Region: 2020-2031
- 5.2.1 Global Lurasidone Hydrochloride Generics Sales by Region: 2020-2025
- 5.2.2 Global Lurasidone Hydrochloride Generics Sales by Region: 2026-2031
- 5.3 Global Lurasidone Hydrochloride Generics Revenue by Region: 2020-2031
- 5.3.1 Global Lurasidone Hydrochloride Generics Revenue by Region: 2020-2025
- 5.3.2 Global Lurasidone Hydrochloride Generics Revenue by Region: 2026-2031
- 5.4 North America Lurasidone Hydrochloride Generics Market Facts & Figures by Country
- 5.4.1 North America Lurasidone Hydrochloride Generics Market Size by Country: 2020 VS 2024 VS 2031
- 5.4.2 North America Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
- 5.4.3 North America Lurasidone Hydrochloride Generics Revenue by Country (2020-2031)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Lurasidone Hydrochloride Generics Market Facts & Figures by Country
- 5.5.1 Europe Lurasidone Hydrochloride Generics Market Size by Country: 2020 VS 2024 VS 2031
- 5.5.2 Europe Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
- 5.5.3 Europe Lurasidone Hydrochloride Generics Revenue by Country (2020-2031)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Lurasidone Hydrochloride Generics Market Facts & Figures by Country
- 5.6.1 Asia Pacific Lurasidone Hydrochloride Generics Market Size by Country: 2020 VS 2024 VS 2031
- 5.6.2 Asia Pacific Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
- 5.6.3 Asia Pacific Lurasidone Hydrochloride Generics Revenue by Country (2020-2031)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Lurasidone Hydrochloride Generics Market Facts & Figures by Country
- 5.7.1 South America Lurasidone Hydrochloride Generics Market Size by Country: 2020 VS 2024 VS 2031
- 5.7.2 South America Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
- 5.7.3 South America Lurasidone Hydrochloride Generics Revenue by Country (2020-2031)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Lurasidone Hydrochloride Generics Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Lurasidone Hydrochloride Generics Market Size by Country: 2020 VS 2024 VS 2031
- 5.8.2 Middle East and Africa Lurasidone Hydrochloride Generics Sales by Country (2020-2031)
- 5.8.3 Middle East and Africa Lurasidone Hydrochloride Generics Revenue by Country (2020-2031)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
- 6 Segment by Type
- 6.1 Global Lurasidone Hydrochloride Generics Sales by Type (2020-2031)
- 6.1.1 Global Lurasidone Hydrochloride Generics Sales by Type (2020-2031) & (K Units)
- 6.1.2 Global Lurasidone Hydrochloride Generics Sales Market Share by Type (2020-2031)
- 6.2 Global Lurasidone Hydrochloride Generics Revenue by Type (2020-2031)
- 6.2.1 Global Lurasidone Hydrochloride Generics Sales by Type (2020-2031) & (US$ Million)
- 6.2.2 Global Lurasidone Hydrochloride Generics Revenue Market Share by Type (2020-2031)
- 6.3 Global Lurasidone Hydrochloride Generics Price by Type (2020-2031)
- 7 Segment by Application
- 7.1 Global Lurasidone Hydrochloride Generics Sales by Application (2020-2031)
- 7.1.1 Global Lurasidone Hydrochloride Generics Sales by Application (2020-2031) & (K Units)
- 7.1.2 Global Lurasidone Hydrochloride Generics Sales Market Share by Application (2020-2031)
- 7.2 Global Lurasidone Hydrochloride Generics Revenue by Application (2020-2031)
- 7.2.1 Global Lurasidone Hydrochloride Generics Sales by Application (2020-2031) & (US$ Million)
- 7.2.2 Global Lurasidone Hydrochloride Generics Revenue Market Share by Application (2020-2031)
- 7.3 Global Lurasidone Hydrochloride Generics Price by Application (2020-2031)
- 8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Lurasidone Hydrochloride Generics Value Chain Analysis
- 8.1.1 Lurasidone Hydrochloride Generics Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Lurasidone Hydrochloride Generics Production Mode & Process
- 8.2 Lurasidone Hydrochloride Generics Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Lurasidone Hydrochloride Generics Distributors
- 8.2.3 Lurasidone Hydrochloride Generics Customers
- 9 Global Lurasidone Hydrochloride Generics Analyzing Market Dynamics
- 9.1 Lurasidone Hydrochloride Generics Industry Trends
- 9.2 Lurasidone Hydrochloride Generics Industry Drivers
- 9.3 Lurasidone Hydrochloride Generics Industry Opportunities and Challenges
- 9.4 Lurasidone Hydrochloride Generics Industry Restraints
- 10 Report Conclusion
- 11 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
